Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells

Various new drugs have been developed for treating recurrent hormone receptor-positive (HR+)/human epidermal receptor 2-negative (HER2−) breast cancer. However, directly identifying effective drugs remains difficult. In this study, we elucidated the clinical relevance of cultured cells derived from...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimoto, Rei, Yogosawa, Satomi, Saijo, Hiroki, Fushimi, Atsushi, Nogi, Hiroko, Asakura, Tadashi, Yoshida, Kiyotsugu, Takeyama, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746954/
https://www.ncbi.nlm.nih.gov/pubmed/31527634
http://dx.doi.org/10.1038/s41598-019-49775-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746954/
https://www.ncbi.nlm.nih.gov/pubmed/31527634
http://dx.doi.org/10.1038/s41598-019-49775-w

Ejemplares similares